Abstract Details

Title Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan Compared to Placebo for Acute Treatment of Migraine

Topic General Neurology: Overview

Presentation(s) S50 - (-)

Poster/Presentation
Number 008

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Linda Wietecha, RN, MS (Eli Lilly & Company) PRESENTER	Ms. Wietecha has received personal compensation for serving as an employee of Eli Lilly and Company. Ms. Wietecha has received stock or an ownership interest from Eli Lilly and Company.
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ����